{"id":"https://openalex.org/W2007458783","doi":"https://doi.org/10.4155/ppa.14.23","title":"Toward Selective TYK2 Inhibitors As Therapeutic Agents for the Treatment of Inflammatory Diseases","display_name":"Toward Selective TYK2 Inhibitors As Therapeutic Agents for the Treatment of Inflammatory Diseases","publication_year":2014,"publication_date":"2014-07-01","ids":{"openalex":"https://openalex.org/W2007458783","doi":"https://doi.org/10.4155/ppa.14.23","mag":"2007458783","pmid":"https://pubmed.ncbi.nlm.nih.gov/25291316"},"language":"en","primary_location":{"id":"doi:10.4155/ppa.14.23","doi":"https://doi.org/10.4155/ppa.14.23","is_oa":false,"landing_page_url":"https://doi.org/10.4155/ppa.14.23","pdf_url":null,"source":{"id":"https://openalex.org/S2764428516","display_name":"Pharmaceutical Patent Analyst","issn_l":"2046-8954","issn":["2046-8954","2046-8962"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Patent Analyst","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078964923","display_name":"Christel J. Menet","orcid":"https://orcid.org/0000-0003-3928-5608","observed_orcids":["https://orcid.org/0000-0003-3928-5608"]},"institutions":[{"id":"https://openalex.org/I85459889","display_name":"Galapagos (Belgium)","ror":"https://ror.org/04e4j5d46","country_code":"BE","type":"company","lineage":["https://openalex.org/I85459889"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Christel J Menet","raw_affiliation_strings":["Department of Medicinal Chemistry, Galapagos NV, Generaal de Wittelaan L11A3, 2800 Mechelen, Belgium: E-mail Address: christel.menet@glpg.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Galapagos NV, Generaal de Wittelaan L11A3, 2800 Mechelen, Belgium: E-mail Address: christel.menet@glpg.com","institution_ids":["https://openalex.org/I85459889"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078964923"],"corresponding_institution_ids":["https://openalex.org/I85459889"],"apc_list":null,"apc_paid":null,"fwci":0.5311,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.60764068,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"3","issue":"4","first_page":"449","last_page":"466"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tyk2-inhibitor","display_name":"TYK2 inhibitor","score":0.9639999866485596},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.6710000038146973},{"id":"https://openalex.org/keywords/cytokine-signaling","display_name":"cytokine signaling","score":0.9380000233650208},{"id":"https://openalex.org/keywords/inflammatory-diseases","display_name":"inflammatory diseases","score":0.972000002861023},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.8240000009536743},{"id":"https://openalex.org/keywords/patents","display_name":"patents","score":0.6330000162124634},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.546999990940094},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.5009999871253967}],"concepts":[{"id":"https://openalex.org/C130523297","wikidata":"https://www.wikidata.org/wiki/Q14914487","display_name":"Tyrosine kinase 2","level":5,"score":0.6712729930877686},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5182954668998718},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5168624520301819},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.4863060414791107},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48528000712394714},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4839823246002197},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.47842079401016235},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4636607766151428},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.43521666526794434},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.41726404428482056},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2987358570098877},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25877904891967773},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23909643292427063},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17952227592468262},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17772233486175537},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.0},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D053612","descriptor_name":"Janus Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D053612","descriptor_name":"Janus Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D053612","descriptor_name":"Janus Kinases","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D053634","descriptor_name":"TYK2 Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053634","descriptor_name":"TYK2 Kinase","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4155/ppa.14.23","doi":"https://doi.org/10.4155/ppa.14.23","is_oa":false,"landing_page_url":"https://doi.org/10.4155/ppa.14.23","pdf_url":null,"source":{"id":"https://openalex.org/S2764428516","display_name":"Pharmaceutical Patent Analyst","issn_l":"2046-8954","issn":["2046-8954","2046-8962"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Patent Analyst","raw_type":"journal-article"},{"id":"pmid:25291316","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25291316","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical patent analyst","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W114839291","https://openalex.org/W1488329660","https://openalex.org/W1835322860","https://openalex.org/W1969979508","https://openalex.org/W1973209866","https://openalex.org/W1975453422","https://openalex.org/W1983236550","https://openalex.org/W1984342091","https://openalex.org/W1985027171","https://openalex.org/W2025277793","https://openalex.org/W2026424254","https://openalex.org/W2042960115","https://openalex.org/W2062946502","https://openalex.org/W2065307318","https://openalex.org/W2071105442","https://openalex.org/W2077384771","https://openalex.org/W2079317282","https://openalex.org/W2089330303","https://openalex.org/W2095543695","https://openalex.org/W2112664453","https://openalex.org/W2121008892","https://openalex.org/W2128124948","https://openalex.org/W2128876481","https://openalex.org/W2132776121","https://openalex.org/W2133657961","https://openalex.org/W2135424108","https://openalex.org/W2152748900","https://openalex.org/W2158649716","https://openalex.org/W2414233995"],"related_works":["https://openalex.org/W2911145904","https://openalex.org/W4360599721","https://openalex.org/W2025277793","https://openalex.org/W4412980834","https://openalex.org/W4396699474","https://openalex.org/W4405730265","https://openalex.org/W4280628150","https://openalex.org/W114839291","https://openalex.org/W4321462477","https://openalex.org/W4404878724"],"abstract_inverted_index":{"The":[0,23],"family":[1],"of":[2,25,39,48,52,66,79,85,99,107,111],"JAK":[3,26,42,71],"comprises":[4],"four":[5],"members":[6],"and":[7,60],"has":[8,73,93],"received":[9],"significant":[10],"attention":[11,92],"in":[12],"recent":[13],"years":[14],"from":[15],"the":[16,46,64,86,97,104,119],"pharmaceutical":[17],"industry":[18,91],"as":[19],"a":[20,49,75],"therapeutic":[21],"target.":[22],"role":[24],"is":[27,34],"central":[28],"to":[29,45,63,118],"cytokine":[30],"signaling":[31],"pathways.":[32],"It":[33],"believed":[35],"that":[36,90],"selective":[37,70],"modulation":[38],"one":[40],"specific":[41,100],"can":[43],"lead":[44],"inhibition":[47,72],"restricted":[50],"set":[51],"cytokines,":[53],"which":[54],"should":[55],"avoid":[56],"undesired":[57],"side":[58],"effects":[59],"get":[61],"closer":[62],"profile":[65],"biologic":[67],"therapies.":[68],"Consequently,":[69],"become":[74],"major":[76],"focus":[77],"area":[78],"drug":[80],"discovery":[81],"research.":[82],"A":[83],"review":[84],"TYK2":[87],"patents":[88],"indicates":[89],"recently":[94],"turned":[95],"toward":[96],"development":[98],"inhibitors.":[101],"Importantly,":[102],"despite":[103],"increasing":[105],"number":[106],"published":[108],"patents,":[109],"none":[110],"these":[112],"drugs":[113],"have":[114],"yet":[115],"made":[116],"it":[117],"clinical":[120],"trials.":[121]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}